The agency that distributed nearly half of all clean syringes provided to drug users in West Virginia last year will end its ...
Now imagine swapping some of that hardware for medicated skin cream that never pokes your skin. That is the vision behind a new Nature study describing a polymer that can haul insulin straight through ...
While Dr Imran Patel’s intentions appeared pure, viewers felt he went a little too far in trying to pacify a toddler during ...
The Injector Collective is a revolutionary platform designed specifically for licensed injectors and medspa professionals. It ...
The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.
First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing option in all approved indications provides greater dosing ...
20h
Regeneron Wins FDA Nod For Eylea HD With Reduced Injection Schedule For Patients With Vision Loss
FDA approves Regeneron's Eylea HD for retinal vein occlusion, adding extended dosing options and greater flexibility across ...
THE call went out from Council for a medically supervised injection centre be trialled in Limerick City due to the high ...
Pharmaceutical Technology on MSN
Regeneron’s Eylea franchise boosted by pair of FDA approvals
Regeneron has won two US Food and Drug Administration (FDA) approvals for Eylea HD (aflibercept), adding another indication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback